Publications by authors named "Rainer F Storb"

Claim this Profile
T
Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression.
Megan A Manson, Feng Zhang, Alexander Novokhodko, Chun-Yu Chen, Maura Parker, Rainer F Storb

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma.
Camille E Puronen, Ryan D Cassaday, Philip A Stevenson, Brenda M Sandmaier, Mary E Flowers, Rainer F Storb

Biol Blood Marrow Transplant· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.
Ryan D Cassaday, D Alan Potts, Philip A Stevenson, Merav Bar, George E Georges, Rainer F Storb

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.
Ryan D Cassaday, Barry E Storer, Mohamed L Sorror, Brenda M Sandmaier, Katherine A Guthrie, Rainer F Storb

Biol Blood Marrow Transplant· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.
Manuela Matesan, Joseph Rajendran, Oliver W Press, David G Maloney, Rainer F Storb

Nucl Med Commun· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.
Mohamed L Sorror, Rainer F Storb, Brenda M Sandmaier, Richard T Maziarz, Michael A Pulsipher

J Clin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.
Mohamed L Sorror, Paul J Martin, Rainer F Storb, Smita Bhatia, Richard T Maziarz

Blood· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.
Yoshihiro Inamoto, Paul J Martin, Barry E Storer, Marco Mielcarek, Rainer F Storb

Haematologica· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers.
Misty L Noble, Christian S Kuhr, Scott S Graves, Keith R Loeb, Samuel S Sun, Rainer F Storb

Mol Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation.
Mohamed L Sorror, Rainer F Storb

Mediterr J Hematol Infect Dis· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of graft-vs.-host disease.
Andrew R Rezvani, Rainer F Storb

Expert Opin Pharmacother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
Andrew R Rezvani, Barry E Storer, Rainer F Storb, Marco Mielcarek, David G Maloney

Biol Blood Marrow Transplant· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.
Ron Ram, Ted A Gooley, David G Maloney, Oliver W Press, John M Pagel, Rainer F Storb

Biol Blood Marrow Transplant· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation.
Yoshihiro Inamoto, Alexander Fefer, Brenda M Sandmaier, Theodore A Gooley, Edus H Warren, Rainer F Storb

Biol Blood Marrow Transplant· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.
Jean E Sanders, Ann E Woolfrey, Paul A Carpenter, Barry E Storer, Paul A Hoffmeister, Rainer F Storb

Blood· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Yoshihiro Inamoto, Mary E D Flowers, Frederick R Appelbaum, Paul A Carpenter, H Joachim Deeg, Rainer F Storb

Biol Blood Marrow Transplant· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.
Ajay K Gopal, Katherine A Guthrie, Joseph Rajendran, John M Pagel, George Oliveira, Rainer F Storb

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.
Yoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, Paul A Carpenter, Edus H Warren, Rainer F Storb

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Mary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, Stephanie J Lee, Hans-Peter Kiem, Rainer F Storb

Blood· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation: the state of the art.
Boglarka Gyurkocza, Andrew Rezvani, Rainer F Storb

Expert Rev Hematol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
Lisa A Palmer, George E Sale, John I Balogun, Dan Li, Dan Jones, Rainer F Storb

Biol Blood Marrow Transplant· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.
Marcello Rotta, Barry E Storer, Rainer F Storb, Paul J Martin, Shelly Heimfeld

Blood· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.
Paul J Martin, George W Counts, Frederick R Appelbaum, Stephanie J Lee, Jean E Sanders, Rainer F Storb

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease.
Qing Ma, Ted A Gooley, Rainer F Storb

Biol Blood Marrow Transplant· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.
John M Pagel, Theodore A Gooley, Joseph Rajendran, Darrell R Fisher, Wendy A Wilson, Rainer F Storb

Blood· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis